WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
Renal cell carcinoma (RCC) is a malignancy with poor prognosis. WNT/β-catenin signaling dysregulation, especially β-catenin overactivation and WNT antagonist silencing, is associated with RCC carcinogenesis and progression. However, the role of WNT ligands in RCC has not yet been determined. We scre...
Main Authors: | Ren-Jun Hsu, Jar-Yi Ho, Tai-Lung Cha, Dah-Shyong Yu, Chieh-Lin Wu, Wei-Ping Huang, Pauling Chu, Ying-Hsin Chen, Jiann-Torng Chen, Cheng-Ping Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3477117?pdf=render |
Similar Items
-
Wnt/β-Catenin Signaling and Obesity
by: Na Chen, et al.
Published: (2018-07-01) -
LATS2 Suppresses Oncogenic Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction
by: Jiong Li, et al.
Published: (2020-06-01) -
LATS2 Suppresses Oncogenic Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction
by: Jiong Li, et al.
Published: (2013-12-01) -
Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
by: Chung-Ming Lin, et al.
Published: (2017-03-01) -
Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis
by: Twan J. J. de Winter, et al.
Published: (2021-02-01)